DrugPatentWatch Database Preview
Drugs in Development Information for D-Proline
Email this page to a colleague
What is the drug development status for D-Proline?
D-Proline is an investigational drug.
There have been 4 clinical trials for D-Proline.
The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2015.
The most common disease conditions in clinical trials are Polycythemia Vera, Polycythemia, and Leukemia, Myelogenous, Chronic, BCR-ABL Positive. The leading clinical trial sponsors are AOP Orphan Pharmaceuticals AG, Fondazione per la Ricerca Ospedale Maggiore, and PharmaEssentia Corporation (Co-Sponsor for USA).
There is one US patent protecting this investigational drug and ten international patents.
Summary for D-Proline
| US Patents | 1,289 |
| International Patents | 10,642 |
| US Patent Applications | 2,136 |
| WIPO Patent Applications | 1,370 |
| Japanese Patent Applications | 641 |
| Clinical Trial Progress | Phase 3 (2015-07-01) |
| Vendors | 94 |
Recent Clinical Trials for D-Proline
| Title | Sponsor | Phase |
|---|---|---|
| ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission | AOP Orphan Pharmaceuticals AG | Phase 2 |
| ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission | Deutsche Krebshilfe e.V., Bonn (Germany) | Phase 2 |
| ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission | Philipps University Marburg Medical Center | Phase 2 |
Clinical Trial Summary for D-Proline
Top disease conditions for D-Proline
Top clinical trial sponsors for D-Proline
US Patents for D-Proline
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| D-Proline | Get Started Free | Template-fixed peptidomimetics | POLYPHOR LTD. (Allschwil, CH) | Get Started Free |
| D-Proline | Get Started Free | Generation of cytotoxic tumor specific cell lines and uses thereof | Ramot at Tel-Aviv University Ltd. (Tel-Aviv, IL) | Get Started Free |
| D-Proline | Get Started Free | Nuclear targeting sequences | Yeda Research and Development Co. Ltd. (Rehovot, IL) | Get Started Free |
| D-Proline | Get Started Free | Self-assembled Fmoc-ff hydrogels | Romat at Tel-Aviv University Ltd. (Tel-Aviv, IL) | Get Started Free |
| D-Proline | Get Started Free | Neprilysin inhibitors | THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) | Get Started Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for D-Proline
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| D-Proline | Australia | AU2007345497 | 2027-01-29 | Get Started Free |
| D-Proline | Canada | CA2676865 | 2027-01-29 | Get Started Free |
| D-Proline | European Patent Office | EP2114986 | 2027-01-29 | Get Started Free |
| D-Proline | Spain | ES2425575 | 2027-01-29 | Get Started Free |
| D-Proline | World Intellectual Property Organization (WIPO) | WO2008092281 | 2027-01-29 | Get Started Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
